<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146">
  <!-- This xml conforms to:  http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>Information obtained from ClinicalTrials.gov on October 20, 2011</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01210950</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Bone-006</org_study_id>
    <nct_id>NCT01210950</nct_id>
  </id_info>
  <brief_title>Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation</brief_title>
  <official_title>Autologous Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Distraction Osteogenesis in Patients With Limb-length Discrepancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <authority>Iran: Ethics Committee</authority>
    <authority>Iran: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Limb-length discrepancy can be due to many causes. These are divided into three groups:
      congenital (from birth), developmental (from a childhood disease or injury that slows or
      damages the growth plates), and posttraumatic (from a fracture that leads to shortening of
      the bone ends). There are three ways to equalize the limb-length discrepancy: use a shoe
      lift, shorten the long leg, lengthen the short leg. Most patients do not like wearing a lift
      greater than 2 cm (3/4 in). For discrepancies greater than 2 cm but less than 5 cm (2 in),
      shortening of the long leg can be considered, especially for tall persons. For growing
      children, this can be easily accomplished with a small, minimally invasive, uncomplicated
      procedure called epiphysiodesis.The investigators aim to evaluate if injection of bone
      marrow derived mesenchymal stem cells can shorten the treatment period by acceleration of
      bone regeneration during distraction osteogenesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Distraction osteogenesis has been widely utilized to treat leg length discrepancy,
      deformity, nonunion, osteomyelitis, and bone loss. It has been found that most difficult
      conditions can be resolved with this method. In this study the aim is to observe if
      mesenchymal stem cell transplantation can enhance new bone formation during distraction
      osteogenesis.Patients undergo bone distraction , and about 2-3 weeks after distraction
      mesenchymal stem cell are injected at the callus site. In the case of large bone gap,
      mesenchymal stem cells are seeded on bone matrix and then placed in the bone gap. Each
      patient is assessed at interval time of 1 month for 6 months post surgery by X-Ray and at
      month 6 post surgery by computed tomography(CT) scans.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification:  Safety Study, Intervention Model:  Single Group Assignment, Masking:  Open Label, Primary Purpose:  Treatment</study_design>
  <primary_outcome>
    <measure>effect of mesenchymal cell transplantation to decrease limb inequal</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>evaluate the effect of mesenchymal cells transplantation with plasma reach protein in limb lengthening and decrease limb inequal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>improve life quality</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>mesenchymal cells transplantation improve patients life quality</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Leg Length Inequality</condition>
  <arm_group>
    <arm_group_label>cell and RPR recepients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mesenchymal cells and plasma reach protein are injected to the callus center of short limb</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>cell and RPR injection</intervention_name>
    <description>mesenchymal cells and Plasma reach Protein are injected to the callus center</description>
    <arm_group_label>cell and RPR recepients</arm_group_label>
    <other_name>cell therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both gender

          -  patient with limb-length discrepancy

          -  Age:18-65

        Exclusion Criteria:

          -  Diagnosis of cancer,DM,CNS disorder,thyroid disease or respiratory disease

          -  Known allergic reaction to components of study treatment and/or study injection
             procedure

          -  Patients infected with hepatitis B,C or HIV

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Gourabi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>President of Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad reza Baghban Eslami Nejad, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Board scientific</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohssen Emadeddin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopadic Investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nasser Aghdami, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Regenerative center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nasser Aghdami, MD,PhD</last_name>
    <phone>+98-02122172332</phone>
    <email>nasser.aghdami@royaninstitute.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leila Arab, MD</last_name>
    <phone>+98-02122172332</phone>
    <email>leila.arab@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nasser Aghdami, MD,PhD</last_name>
      <phone>+98-02122172332</phone>
      <email>nasser.aghdami@royaninstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>Leila Arab, MD</last_name>
      <phone>+98-02122172332</phone>
      <email>Leila.arab@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Leila Taghiar, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reza Moghaddas Ali, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Soura Mardpour, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roghaieh Fazeli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>motalebi zadeh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.royaninstitute.org</url>
    <description>Royan Institute</description>
  </link>
  <verification_date>April 2008</verification_date>
  <lastchanged_date>October 2, 2010</lastchanged_date>
  <firstreceived_date>September 25, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Hamid Gourabi/President of Royan Institute</name_title>
    <organization>Royan Institute</organization>
  </responsible_party>
  <keyword>distraction</keyword>
  <keyword>osteogenesis</keyword>
  <keyword>limb length discrepancy</keyword>
  <keyword>callus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leg Length Inequality</mesh_term>
  </condition_browse>
</clinical_study>
